Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending April 21, 2023.
Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
Featured in our print April edition, psychosis is estimated to affect more than half of patients with Parkinson disease, and there is a growing need for improved management and therapeutic development.
In episode 2 of this Peer Exchange series on "Advances in the Management of Excessive Daytime Sleepiness and Narcolepsy", experts in neurology provide an overview of excessive daytime sleepiness and narcolepsy.
In the latest edition of our in-depth Q&A series, director of the Memory & Cognitive Disorders Clinic at Hoag Neuroscience Institute, provided perspective on the recently launched program for Parkinson disease.
In episode 2 of this Cure Connection series, "The Patient Journey in the Management of Multiple Sclerosis," experts highlight the role of comprehensive care and importance of treatment adherence for people living with multiple sclerosis.
The research fellow at the Neuroimmunology Clinic and Research Laboratory, Massachusetts General Hospital and Harvard Medical School shared what he is excited about regarding presenting his data at the 2023 American Academy of Neurology (AAN) Annual Meeting, April 22-27, in Boston, Massachusetts.